Progress in individualized treatment for EGFR-mutated advanced non-small cell lung cancer

The identification of mutations in the epidermal growth factor receptor (EGFR) gene has revolutionized the treatment strategy for non-small cell lung cancer (NSCLC). The effectiveness of individualized treatment using EGFR tyrosine kinase inhibitors (TKIs) for EGFR-mutated NSCLC has mainly been clar...

Descripción completa

Detalles Bibliográficos
Autor principal: INOUE, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japan Academy 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443375/
https://www.ncbi.nlm.nih.gov/pubmed/32788550
http://dx.doi.org/10.2183/pjab.96.020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443375/
https://www.ncbi.nlm.nih.gov/pubmed/32788550
http://dx.doi.org/10.2183/pjab.96.020

Ejemplares similares